Key result
A manually titrated prophylactic norepinephrine infusion significantly reduced cumulative episodes of hypotension compared to rescue bolus therapy during cesarean section (8 vs 29 episodes; P<0.001).
Why the study?
Norepinephrine is being investigated for mitigation of spinal-induced hypotension, prompting an evaluation of manually titrated norepinephrine infusion for preventing hypotension during cesarean section under subarachnoid block.
Does a prophylactic manually titrated norepinephrine infusion prevent hypotension in parturients undergoing cesarean section under spinal anesthesia?
RCT (n=140)
Double-blind
Randomized
Does a prophylactic manually titrated norepinephrine infusion prevent hypotension in parturients undergoing cesarean section under spinal anesthesia?
Absolute Event Rate: 11.4% vs 41.4%
p-value: p=<0.001
Prophylactic manually titrated norepinephrine infusion effectively reduces the incidence of hypotension during spinal anesthesia for cesarean section without adverse neonatal effects.
Titrated norepinephrine infusion cuts spinal hypotension episodes in cesarean delivery; confirms prophylactic vasopressor efficacy in obstetric RCTs.
Background and Aims: Norepinephrine is recently being investigated for mitigation of spinal-induced hypotension. Our study aimed at evaluating the role of manually titrated infusion of norepinephrine in preventing hypotension in patients undergoing lower segment cesarean section (LSCS) under subarachnoid block (SAB). Subjects and Methods: This prospective, randomized, double-blind, placebo-controlled trial was conducted in 140 parturients undergoing LSCS under SAB. Patients were randomly allocated to two groups: group A received an infusion of 5 µg/mL norepinephrine started at 30 mL/h (2.5 µg/min) immediately after SAB and manually adjusted within the range 0–60 mL/h (0–5 µg/min), according to the values of systolic blood pressure (SBP) until delivery; in group B, no prophylactic vasopressor was given, and bolus 1 mL norepinephrine (5 µg) was given whenever the SBP decreased to <80% of the baseline value. Groups were compared with regard to the incidence of hypotension, hemodynamic parameters, and norepinephrine consumption. Categorical data were presented as number and compared using the Chi-square test. Continuous variables were presented as mean ± standard deviation (SD) and compared using t -test. P <0.05 was considered statistically significant. Results: Cumulative episodes of hypotension were significantly lesser in group A (eight) than group B (29) ( P < 0.001). Mean time of onset of hypotension was significantly higher in group A (19.75 ± 8.24 min) compared to group B (4.36 ± 0.77 min) ( P < 0.001). Mean SBP, diastolic blood pressure (DBP), and mean arterial pressure (MAP) were significantly higher in group A compared to group B intraoperatively ( P < 0.001). Mean heart rate (HR) was significantly lower in group A compared to group B ( P < 0.05). Neonatal outcomes were comparable between both the groups. Conclusions: In patients undergoing SAB for LSCS, a manually titrated infusion of 5 µg/mL of norepinephrine was effective for maintaining BP and decreasing the incidence of hypotension, with no detectable detrimental effect on neonatal outcome.
No takes yet. Share an insight, caveat, or question.
Bedi et al. (2024) conducted an RCT in Cesarean section under spinal anesthesia (n=140). Norepinephrine infusion vs. No prophylactic vasopressor (bolus 5 µg norepinephrine rescue) was evaluated on Cumulative episodes of hypotension (p=<0.001). A manually titrated prophylactic norepinephrine infusion significantly reduced cumulative episodes of hypotension compared to rescue bolus therapy during cesarean section (8 vs 29 episodes; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: